BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11717448)

  • 1. Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice.
    Goudy K; Song S; Wasserfall C; Zhang YC; Kapturczak M; Muir A; Powers M; Scott-Jorgensen M; Campbell-Thompson M; Crawford JM; Ellis TM; Flotte TR; Atkinson MA
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13913-8. PubMed ID: 11717448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant adeno-associated virus-mediated alpha-1 antitrypsin gene therapy prevents type I diabetes in NOD mice.
    Song S; Goudy K; Campbell-Thompson M; Wasserfall C; Scott-Jorgensen M; Wang J; Tang Q; Crawford JM; Ellis TM; Atkinson MA; Flotte TR
    Gene Ther; 2004 Jan; 11(2):181-6. PubMed ID: 14712302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene delivery GAD 500 autoantigen by AAV serotype 1 prevented diabetes in NOD mice: transduction efficiency do not play important roles.
    Han G; Wang R; Chen G; Wang J; Xu R; Feng J; Yu M; Wu X; Qian J; Shen B; Li Y
    Immunol Lett; 2008 Jan; 115(2):110-6. PubMed ID: 18045698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of adoptively transferred diabetes in nonobese diabetic mice with IL-10-transduced islet-specific Th1 lymphocytes. A gene therapy model for autoimmune diabetes.
    Moritani M; Yoshimoto K; Ii S; Kondo M; Iwahana H; Yamaoka T; Sano T; Nakano N; Kikutani H; Itakura M
    J Clin Invest; 1996 Oct; 98(8):1851-9. PubMed ID: 8878437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic overexpression of IL-10 induces CD4+CD25+ cell populations in vivo and ameliorates type 1 diabetes in nonobese diabetic mice in a dose-dependent fashion.
    Goudy KS; Burkhardt BR; Wasserfall C; Song S; Campbell-Thompson ML; Brusko T; Powers MA; Clare-Salzler MJ; Sobel ES; Ellis TM; Flotte TR; Atkinson MA
    J Immunol; 2003 Sep; 171(5):2270-8. PubMed ID: 12928371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy of spontaneous type 1 diabetes in nonobese diabetic mice by systemic interleukin-4 treatment employing adenovirus vector-mediated gene transfer.
    Cameron MJ; Arreaza GA; Waldhauser L; Gauldie J; Delovitch TL
    Gene Ther; 2000 Nov; 7(21):1840-6. PubMed ID: 11110416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intramuscular administration of expression plasmids encoding interferon-gamma receptor/IgG1 or IL-4/IgG1 chimeric proteins protects from autoimmunity.
    Chang Y; Prud'homme GJ
    J Gene Med; 1999; 1(6):415-23. PubMed ID: 10753067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-beta1 somatic gene therapy prevents autoimmune disease in nonobese diabetic mice.
    Piccirillo CA; Chang Y; Prud'homme GJ
    J Immunol; 1998 Oct; 161(8):3950-6. PubMed ID: 9780163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined administration of plasmids encoding IL-4 and IL-10 prevents the development of autoimmune diabetes in nonobese diabetic mice.
    Ko KS; Lee M; Koh JJ; Kim SW
    Mol Ther; 2001 Oct; 4(4):313-6. PubMed ID: 11592833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inducible adeno-associated virus-mediated IL-2 gene therapy prevents autoimmune diabetes.
    Goudy KS; Johnson MC; Garland A; Li C; Samulski RJ; Wang B; Tisch R
    J Immunol; 2011 Mar; 186(6):3779-86. PubMed ID: 21317396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice.
    Shapiro AM; Suarez-Pinzon WL; Power R; Rabinovitch A
    Diabetologia; 2002 Feb; 45(2):224-30. PubMed ID: 11935154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Th17 polarized cells from nonobese diabetic mice following mycobacterial adjuvant immunotherapy delay type 1 diabetes.
    Nikoopour E; Schwartz JA; Huszarik K; Sandrock C; Krougly O; Lee-Chan E; Singh B
    J Immunol; 2010 May; 184(9):4779-88. PubMed ID: 20363968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of autoimmune diabetes by immunogene therapy using recombinant vaccinia virus expressing glutamic acid decarboxylase.
    Jun HS; Chung YH; Han J; Kim A; Yoo SS; Sherwin RS; Yoon JW
    Diabetologia; 2002 May; 45(5):668-76. PubMed ID: 12107747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A noncytolytic IL-10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice.
    Zheng XX; Steele AW; Hancock WW; Stevens AC; Nickerson PW; Roy-Chaudhury P; Tian Y; Strom TB
    J Immunol; 1997 May; 158(9):4507-13. PubMed ID: 9127018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral IL-10-mediated immune regulation in pancreatic islet transplantation.
    Carter JD; Ellett JD; Chen M; Smith KM; Fialkow LB; McDuffie MJ; Tung KS; Nadler JL; Yang Z
    Mol Ther; 2005 Aug; 12(2):360-8. PubMed ID: 16043104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adeno-associated virus-mediated IL-10 gene therapy inhibits diabetes recurrence in syngeneic islet cell transplantation of NOD mice.
    Zhang YC; Pileggi A; Agarwal A; Molano RD; Powers M; Brusko T; Wasserfall C; Goudy K; Zahr E; Poggioli R; Scott-Jorgensen M; Campbell-Thompson M; Crawford JM; Nick H; Flotte T; Ellis TM; Ricordi C; Inverardi L; Atkinson MA
    Diabetes; 2003 Mar; 52(3):708-16. PubMed ID: 12606512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-10 plasmid construction and delivery for the prevention of type 1 diabetes.
    Lee M; Park H; Youn J; Oh ET; Ko K; Kim S; Park Y
    Ann N Y Acad Sci; 2006 Oct; 1079():313-9. PubMed ID: 17130572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of autoimmune diabetes by viral IL-10 gene transfer.
    Yang Z; Chen M; Wu R; Fialkow LB; Bromberg JS; McDuffie M; Naji A; Nadler JL
    J Immunol; 2002 Jun; 168(12):6479-85. PubMed ID: 12055268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A murine interleukin-4-Ig fusion protein regulates the expression of Th1- and Th2-specific cytokines in the pancreas of NOD mice.
    Walz M; Overbergh L; Mathieu C; Kolb H; Martin S
    Horm Metab Res; 2002 Oct; 34(10):561-9. PubMed ID: 12439784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. dsAAV8-mediated gene transfer and β-cell expression of IL-4 and β-cell growth factors are capable of reversing early-onset diabetes in NOD mice.
    Gaddy DF; Riedel MJ; Bertera S; Kieffer TJ; Robbins PD
    Gene Ther; 2012 Aug; 19(8):791-9. PubMed ID: 22089495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.